Learning Objectives: 

1.) Review the literature regarding the efficacy of previous vaccines (influenza) in patients on DMARD therapy. 

2.) Discuss the discovery and mechanism of mRNA vaccines.

3.) Summarize efficacy and safety data for the currently approved mRNA COVID-19 vaccines.  

4.) Review current ACR and EULAR recommendations for COVID-19 vaccination in patients with rheumatic disease. 

 Disclosures:

- None

 CME Code: LUDSUP

Location: virtual (by WebEx only)
Directions: If you are having trouble accessing WebEx, please contact Isaac Smith at isaac.smith063@duke.edu. 

Streaming: Yes, via WebEx. Link:  https://dukemed.webex.com/meet/is120 

Meeting Number/Access Code: 470 543 135  (you will not need this if you use link above)

Call-in number: 1-650-479-3207